[1]
Mohite, S.; Sanches, M.; Teixeira, A.L. Exploring the evidence implicating the Renin- Angiotensin System (RAS) in the physiopathology of mood disorders. Protein Pept. Lett., 2020, 27(6), 449-455.
[2]
Machado, T.C.G.; Guatimosim, C.; Kangussu, L.M. The renin-angiotensin system in Huntington’s disease: Villain or hero? Protein Pept. Lett., 2020, 27(6), 456-462.
[3]
Kangussu, L.M.; Marzano, L.A.S.; Souza, C.F.; Dantas, C.C.; Miranda, A.S.; Simões E Silva, A.C. The renin-angiotensin system and the cerebrovascular diseases: Experimental and clinical evidence. Protein Pept. Lett., 2020, 27(6), 463-475.
[4]
de Melo, L.A.; Almeida-Santos, A.F. Neuropsychiatric properties of the ACE2/Ang-(1-7)/Mas pathway: A brief review. Protein Pept. Lett., 2020, 27(6), 476-483.
[5]
Ribeiro, V.T.; de Souza, L.C.; Simões E Silva, A.C. Renin-angiotensin system and Alzheimer’s disease pathophysiology: From the potential interactions to therapeutic perspectives. Protein Pept. Lett., 2020, 27(6), 484-511.
Protein & Peptide Letters
Title:Renin-Angiotensin System: Role in Cerebrovascular, Neurodegenerative and Psychiatric Disease
Volume: 27 Issue: 6
Author(s): Lucas M. Kangussu
Affiliation:
Export Options
About this article
Cite this article as:
Kangussu M. Lucas , Renin-Angiotensin System: Role in Cerebrovascular, Neurodegenerative and Psychiatric Disease, Protein & Peptide Letters 2020; 27 (6) . https://dx.doi.org/10.2174/092986652706200610104905
DOI https://dx.doi.org/10.2174/092986652706200610104905 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Current Pharmacogenomics and Personalized Medicine Platelets and Atherothrombosis: Causes, Targets and Treatments for Thrombosis
Current Medicinal Chemistry Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules
Current Medicinal Chemistry A Contemporary Approach to Macular Edema Treatment in Retinal Vein Occlusion
Vascular Disease Prevention (Discontinued) Cardiovascular Disease Risk Among the Poor and Homeless – What We Know So Far
Current Cardiology Reviews Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
Current Alzheimer Research Treatment of Insulin Resistance in the Neurodegeneration
Recent Patents on CNS Drug Discovery (Discontinued) Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research
Current Diabetes Reviews Dietary Lipids and Alzheimer’s Disease
Current Alzheimer Research Under the Microscope: Focus on Chlamydia pneumoniae Infection and Multiple Sclerosis
Current Neurovascular Research Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound
CNS & Neurological Disorders - Drug Targets Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Role of Physical Exercise as Complementary Treatment for Epilepsy and other Brain Disorders
Current Pharmaceutical Design Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience
Current Alzheimer Research Ischemic Post-Conditioning Partially Reverses Cell Cycle Reactivity Following Ischemia/Reperfusion Injury: A Genome-Wide Survey
CNS & Neurological Disorders - Drug Targets Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design